Skip to main content

Table 4 Effect of various therapies for metastatic adrenal tumor from HCC

From: Radiotherapy treatment of adrenal gland metastases from hepatocellular carcinoma: clinical features and prognostic factors

Treatment

Author

Time

Case (n)

Tumor

Survival time (from Treatment of adrenal metastases)

Median (months)

Survival rate (1 year)

Survival rate (2 years)

Surgery

Momoi H [5]

2002

13

8/13 have additional organs metastases.

 

51.3%

42%

Park JS [6]

2007

5

With well-controlled intrahepatic foci no additional organs metastases

21.4

100%

50%

Single adrenal metastases

TACE

Momoi H [5]

2002

4

With tumor thrombus or additional organs metastases

5.9, 6.5, 16.1, 21.3 months

 

Taniai N [18]

1999

2

Single adrenal metastases and well-controlled intrahepatic foci

Survived 3 and 8 months (still live)

PEIT

Momoi H [5]

2002

4

additional organs metastases (1 case), intrahepatic tumor (3 case)

7.6, 8.5, 21.4, 32 months

PEIT + TACE

Park JS [6]

2007

19

well-controlled intrahepatic foci, no additional organs metastases

10.5

43

0

RF+ TACE

Yamakado K [19]

2009

6

intrahepatic tumor (T3), additional organs metastases (3 cases), size of metastatic adrenal tumor (3-8 cm)

24.9

  

No treatment

Park JS [6]

2007

6

well-controlled intrahepatic foci, no additional organs metastases

5.6

0%

-

RT

Zhou LY

2014

55

Patients of liver function Child-Pugh C were excluded

13.6

58.7%

32.3%